Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from BrightSpring Health Services, Inc. ( (BTSG) ) is now available.
On June 20, 2025, Michael McMaude resigned from his roles as President of Hospice Services at BrightSpring Health Services, Inc. and CEO of its subsidiary, Abode Healthcare, Inc. His resignation was not due to any disagreements with the company. McMaude will continue as a consultant until January 26, 2027, under a Resignation Agreement that includes a monthly consulting fee and continued vesting of stock options. The agreement also outlines non-competition and non-solicitation clauses for McMaude.
The most recent analyst rating on (BTSG) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on BrightSpring Health Services, Inc. stock, see the BTSG Stock Forecast page.
Spark’s Take on BTSG Stock
According to Spark, TipRanks’ AI Analyst, BTSG is a Outperform.
BrightSpring Health Services shows strong financial health and strategic growth potential, supported by technical indicators and positive earnings guidance. However, the current valuation is high, potentially limiting upside. The strategic divestiture further reinforces its focus on core growth areas.
To see Spark’s full report on BTSG stock, click here.
More about BrightSpring Health Services, Inc.
Average Trading Volume: 2,234,317
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.93B
See more insights into BTSG stock on TipRanks’ Stock Analysis page.